Purchases and Sales Made in Q4 2022 in Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD) during Q4 2022. The information is specifically focused on institutions that hold shares of Prelude Therapeutics Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-66.7K- 2.77% |
$307K - $567K
|
2.34M
$2.22M
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-87.8K- 49.41% |
$405K - $747K
|
89.9K
$85.5K
|